CNS Neuroscience and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.6 | Q1 | 89.0% | 1.741 | Q1 | 93.9% |
| 2024 | 5.0 | Q1 | 87.0% | 1.676 | Q1 | 93.6% |
| 2023 | 4.8 | Q1 | 85.8% | 1.473 | Q1 | 92.4% |
| 2022 | 5.5 | Q1 | 85.9% | 1.381 | Q1 | 92.0% |
| 2021 | 7.0 | Q1 | 91.6% | 1.364 | Q1 | 91.9% |
| 2020 | — | — | 1.403 | Q1 | 91.5% | |
| 2019 | — | — | 1.241 | Q1 | 89.8% | |
| 2018 | — | — | 1.122 | Q1 | 86.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1755-5930
ISSN
1755-5949
region
Western Europe
coverage
2008-2026